Ally Bridge Group PE LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Ally Bridge Group PE LLC
CRD #315273
SEC #801-121989
CIK #
AUM
Employees 18 (72% Investors, 0% Brokers)
Phone646-829-9676
Address430 Park Avenue
New York, NY 10022
Source [IAPD] [Website] [LinkedIn]
Total AUM ($M)
1400112084056028002011201620212026
Type Form D Funds Date Sold AUM
PE Abg-Siv LP [2025-03-31] 5.0 M
Filed 2024-12-06 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
PE Ally Bridge Group Global Life Science Capital Partners V LP [2023-03-31] 32.2 M 266.5 M
Filed 2024-09-20 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
PE Ally Bridge Group ABG 2021-03-30 0.5 M
PE Themes Investment Partners II LP [2021-03-30] 71.3 M 3.0 M
Filed 2011-08-17 (D/A) · Exemption 506, 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Commission $1,000,000 · Revenue Decline to Disclose
PE Ally Bridge Group-WTT Global Life Science Capital Partners LP [2020-03-30] 2.0 M 616.3 M
Filed 2020-12-02 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Commission $1,500,000 · Revenue Decline to Disclose
PE Ally Bridge Group Innovation Capital Partners III LP [2017-03-21] 2.0 M 14.3 M
Filed 2018-05-04 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
PE Ally Bridge Group Capital Partners II LP [2016-03-29] 132.9 M
Filed 2015-05-28 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 19 1,354.0
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 19 1,354.0
By Discretionary
Discretionary 0 0.0
Non-Discretionary 19 1,354.0
Total 19 1,354.0
By Non-United States Persons
Non-United States Persons 1,354.0
United States Persons 0.0
Total 19 1,354.0
Form D Directors Role # Filings # Firms 2011 - 2026
Fan Yu Director 27 4
Shan-Ju Yeh Director 6 2
John Wang Director 5 2
Abg Global Life Science Capital Partners V GP LP Promoter 4 2
Abg Innovation Capital Partners III GP LP Promoter 2 2
Abg Capital Partners II GP LP Promoter 2 2
Ming-Hsing Tsai Director 1 1
Ming-Chung Tsai Director 1 1
Firm Profile (Form ADV)
ServesInstitutional
Fund TypesPrivate Equity
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com